Stockreport

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease with Foralumab [Yahoo! Finance]

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that the U.S. Food and Drug Administration (FDA) has allowed intranasal foralu [Read more]